Cited by 530Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesInfectious Encephalopathies and Encephalitis

Long-term neurologic outcomes of COVID-19

Open access
Xu, Evan, Xie, Yan, Al-Aly, Ziyad·2022·Nature Medicine

Published version of a preprint

Abstract

The neurologic manifestations of acute COVID-19 are well characterized, but a comprehensive evaluation of postacute neurologic sequelae at 1 year has not been undertaken. Here we use the national healthcare databases of the US Department of Veterans Affairs to build a cohort of 154,068 individuals with COVID-19, 5,638,795 contemporary controls and 5,859,621 historical controls; we use inverse probability weighting to balance the cohorts, and estimate risks and burdens of incident neurologic disorders at 12 months following acute SARS-CoV-2 infection. Our results show that in the postacute phase of COVID-19, there was increased risk of an array of incident neurologic sequelae including ischemic and hemorrhagic stroke, cognition and memory disorders, peripheral nervous system disorders, episodic disorders (for example, migraine and seizures), extrapyramidal and movement disorders, mental health disorders, musculoskeletal disorders, sensory disorders, Guillain–Barré syndrome, and encephalitis or encephalopathy. We estimated that the hazard ratio of any neurologic sequela was 1.42 (95% confidence intervals 1.38, 1.47) and burden 70.69 (95% confidence intervals 63.54, 78.01) per 1,000 persons at 12 months. The risks and burdens were elevated even in people who did not require hospitalization during acute COVID-19. Limitations include a cohort comprising mostly White males. Taken together, our results provide evidence of increased risk of long-term neurologic disorders in people who had COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-022-02001-z

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

2 of the 54 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. [18]Xie Y Xu E Bowe B Al-Aly Z Long-term cardiovascular outcomes of COVID-19 Nat. Med. 2022 28 583 590 35132265 PMC8938267
  2. [44]Hu, K., Patel, J., Swiston, C. & Patel, B.C. Ophthalmic Manifestations Of Coronavirus (COVID-19) (StatPearls Publishing LLC, Treasure Island (FL), 2022). 32310553

Cited by

Sorted by citations

Authors
Xu, E., Xie, Y., & Al-Aly, Z.
Affiliations
VA St. Louis Health Care System (US)
Venue
Nature Medicine
Published
2022-09-22
Volume
28
Issue
11
Pages
2406-2415
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4296806570
Cited by
530
References
54
Citations by year
2026: 61 · 2025: 107 · 2024: 168 · 2023: 166 · 2022: 27 · 2020: 1
FWCI
61.58
Type
journal article
Language
en
Open access
Locations
  • Nature Medicine (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
Funders
  • U.S. Department of Veterans Affairs
  • American Society of Nephrology
Topics
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
Keywords
COVID-19 pandemic, SARS-CoV-2, long-term neurologic outcome, stroke, cognitive impairment, Guillain-Barré syndrome, encephalitis, migraine, seizures, movement disorders, mental illness, peripheral nerve disorders, veterans
MeSH terms
COVID-19, SARS-CoV-2, Brain Diseases, Humans, Male, Nervous System Diseases, Guillain-Barre Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review